Literature DB >> 33566486

P012 Ozanimod Reduced Fecal Calprotectin Levels in Patients with Ulcerative Colitis in the Phase 3 True North Study.

Ghosh Subrata1, D'Haens Geert2, Jairath Vipul3, Rieder Florian4, Petersen AnnKatrin5, Usiskin Keith5, Chitkara Denesh5, Colombel Jean-Frederic6.   

Abstract

Entities:  

Year:  2020        PMID： 33566486     DOI： 10.14309/01.ajg.0000722844.18503.37

Source DB:  PubMed          Journal:  Am J Gastroenterol        ISSN： 0002-9270            Impact factor:   10.864


× No keyword cloud information.
  1 in total

Review 1.  Ozanimod: A Review in Ulcerative Colitis.

Authors:  Julia Paik
Journal:  Drugs       Date:  2022-08-22       Impact factor: 11.431
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.